文献速递胃肠外科围术期管理与 ERAS

减重手术后门肠系膜静脉血栓的管理

Management of portomesenteric vein thrombosis following bariatric surgery.
PubMed 文献 · Surg Endosc · 2026-08-21

该多中心回顾性系列纳入2012–2025年間4个中心71例减重术后门肠系膜静脉血栓(PMVT)患者,其中68例腹腔镜袖状胃切除术、3例Roux-en-Y胃旁路术。中位诊断时间为术后13天;仅抗凝组中广泛血栓(主门静脉+肝内门静脉+流入静脉)者76%发生海绵样变,而介入溶栓组为20%(p<0.05)。早期介入干预与海绵样变减少相关。

要点

  • 减重术后PMVT罕见但可致门静脉海绵样变,中位诊断时间为术后13天。
  • 广泛血栓累及主门静脉、肝内门静脉及流入静脉时,仅抗凝的海绵样变风险高。
  • 早期介入放射学溶栓与降低海绵样变风险相关。

核心结论

  • 减重术后PMVT中,广泛型血栓(主门静脉+肝内门静脉+流入静脉)仅抗凝治疗与海绵样变强烈相关,早期介入干预与海绵样变减少相关。

研究设计与样本

  • 多中心回顾性病例系列,查询4个城市减重手术中心2012–2025年诊断为PMVT的患者医疗记录。
  • 共71例减重术后PMVT患者(68例LSG,3例RYGB),中位手术至诊断时间13天。
  • 采用Fisher精确检验分析血栓范围、治疗方式(抗凝 vs 介入放射学溶栓)与海绵样变结局的相关性。

主要发现

  • 71例中3例(4%)因小肠切除需再手术,其中2例行开放血栓清除术、1例后续行介入溶栓。
  • 其余68例中,6/68(9%)接受介入导管导向溶栓,62/68(91%)仅接受抗凝治疗。
  • 53例有长期数据者中,18例(34%)发生海绵样变。
  • 在主门静脉+肝内门静脉+流入静脉(肠系膜上静脉或脾静脉)血栓患者中,仅抗凝组海绵样变13/17(76%),介入组1/5(20%),p<0.05。
  • 无PMVT相关死亡。

临床怎么用

  • 减重术后出现PMVT时,应评估血栓范围,广泛累及主门静脉、肝内门静脉及流入静脉者需警惕海绵样变风险。
  • 对广泛型PMVT,可考虑早期介入放射学溶栓以降低海绵样变风险。

局限性

  • 回顾性设计,样本量有限(71例),仅53例有长期随访数据。
  • 介入溶栓组样本量小(5例广泛血栓者),结果需谨慎解读。
  • 无标准化治疗算法,治疗选择可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Portomesenteric venous thrombosis (PMVT) is a rare complication of bariatric surgery that can lead to cavernous transformation of the portal vein. There are no established treatment algorithms regarding anticoagulation (AC) only vs. catheter-directed thrombolysis in this population. METHODS: Medical records at 4 urban bariatric surgery centers were queried for patients diagnosed with PMVT between 2012 and 2025. Patient characteristics, perioperative details, imaging at PMVT diagnosis, treatment course, and follow-up imaging were reviewed. Fisher's exact testing was conducted to identify correlations between extent of thrombosis, treatment course (anticoagulation vs. interventional radiology [IR] thrombolysis), and the outcome of cavernous transformation. RESULTS: 71 patients were diagnosed with PMVT following bariatric surgery (68 LSG, 3 RYGB) at 4 centers between 2012 and 2025. Median time from surgery to PMVT diagnosis was 13 days. Three patients (4%) required reoperation for small bowel resection, of whom 2 underwent open thrombectomy and 1 underwent subsequent IR thrombolysis. Of the remaining patients, 6/68 (9%) underwent IR catheter-directed thrombolysis, and 62/68 (91%) received AC only. Of 53 patients with long-term data, 18 (34%) developed cavernous transformation. Among patients who had a main portal vein + intrahepatic portal vein + inflow (superior mesenteric vein or splenic vein) thrombosis, treatment with AC only was strongly associated with cavernous transformation (13/17, 76%) vs IR (1/5, 20%, p < 0.05). There were no deaths related to PMVT. CONCLUSIONS: In this largest known case series of postbariatric surgery PMVT treated with anticoagulation vs. IR, we found that the PMVT clot pattern with the highest risk of developing cavernous transformation was the extensive type involving the main portal vein, an intrahepatic portal vein, and an inflow vein, whether the main portal vein clot was occlusive or nonocclusive. Early IR intervention was associated with decreased cavernous transformation.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Kozato A, Hickey RM, Hindman N, et al. Management of portomesenteric vein thrombosis following bariatric surgery. Surg Endosc. 2026. PMID: 42629487. doi:10.1007/s00464-026-13148-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。